1. Home
  2. DMAC vs MX Comparison

DMAC vs MX Comparison

Compare DMAC & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • MX
  • Stock Information
  • Founded
  • DMAC 2000
  • MX 2003
  • Country
  • DMAC United States
  • MX South Korea
  • Employees
  • DMAC N/A
  • MX N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • MX Semiconductors
  • Sector
  • DMAC Health Care
  • MX Technology
  • Exchange
  • DMAC Nasdaq
  • MX Nasdaq
  • Market Cap
  • DMAC 185.1M
  • MX 188.0M
  • IPO Year
  • DMAC N/A
  • MX N/A
  • Fundamental
  • Price
  • DMAC $4.23
  • MX $3.96
  • Analyst Decision
  • DMAC Strong Buy
  • MX Strong Buy
  • Analyst Count
  • DMAC 3
  • MX 2
  • Target Price
  • DMAC $7.00
  • MX $7.50
  • AVG Volume (30 Days)
  • DMAC 34.2K
  • MX 374.9K
  • Earning Date
  • DMAC 11-13-2024
  • MX 10-30-2024
  • Dividend Yield
  • DMAC N/A
  • MX N/A
  • EPS Growth
  • DMAC N/A
  • MX N/A
  • EPS
  • DMAC N/A
  • MX N/A
  • Revenue
  • DMAC N/A
  • MX $219,520,000.00
  • Revenue This Year
  • DMAC N/A
  • MX $1.74
  • Revenue Next Year
  • DMAC N/A
  • MX $18.18
  • P/E Ratio
  • DMAC N/A
  • MX N/A
  • Revenue Growth
  • DMAC N/A
  • MX N/A
  • 52 Week Low
  • DMAC $2.12
  • MX $3.78
  • 52 Week High
  • DMAC $4.95
  • MX $8.16
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 45.24
  • MX 34.89
  • Support Level
  • DMAC $4.14
  • MX $3.78
  • Resistance Level
  • DMAC $4.48
  • MX $4.19
  • Average True Range (ATR)
  • DMAC 0.18
  • MX 0.23
  • MACD
  • DMAC -0.03
  • MX -0.07
  • Stochastic Oscillator
  • DMAC 34.88
  • MX 20.87

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About MX Magnachip Semiconductor Corporation

MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.

Share on Social Networks: